Skip to main content
Neovasc looks to raise $4.25M in public offering

A public offering of over 11 million shares of common stock has been announced by British Columbia-based cardiovascular medtech company Neovasc in hopes of raising $4.25 million in net proceeds. The proceeds will be used as working capital, as well as for product development and general corporate purposes.

Full Story: